Skip to search.
 TSX Down 0.16% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Transition Therapeutics Inc. (TTHI)

-NasdaqGM
5.54 0.07(1.28%) Apr 23, 3:59PM EDT
Add to Portfolio
Prev Close:5.47
Open:5.46
Bid:5.11 x 100
Ask:5.69 x 100
1y Target Est:11.50
Beta:0.98
Next Earnings Date:N/A
Day's Range:5.15 - 5.56
52wk Range:2.05 - 8.22
Volume:54,057
Avg Vol (3m):54,445
Market Cap:164.01M
P/E (ttm):N/A
EPS (ttm):-0.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Must Read

Comparison

Symbol% ChgMkt Cap
TTHIUp 1.28%164.01M
GSK132.09B
MRK169.09B
PFE197.36B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.32
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-14) :-0.56
Quarterly EPS Est (Mar-14) :-0.07
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, develops therapeutics for various disease indications primarily in Canada. Its lead CNS drug candidate includes ELND005, a Phase II clinical trial product for the treatment of Alzheimer... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback